Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Assets Average (2016 - 2021)

Historic Assets Average for Neurocrine Biosciences (NBIX) over the last 11 years, with Q3 2021 value amounting to $2.0 billion.

  • Neurocrine Biosciences' Assets Average rose 3165.79% to $2.0 billion in Q3 2021 from the same period last year, while for Sep 2021 it was $2.0 billion, marking a year-over-year increase of 3165.79%. This contributed to the annual value of $1.5 billion for FY2020, which is 3225.32% up from last year.
  • Latest data reveals that Neurocrine Biosciences reported Assets Average of $2.0 billion as of Q3 2021, which was up 3165.79% from $1.9 billion recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' Assets Average peaked at $2.0 billion during Q3 2021, and registered a low of $327.2 million during Q1 2017.
  • Over the past 5 years, Neurocrine Biosciences' median Assets Average value was $1.0 billion (recorded in 2019), while the average stood at $1.1 billion.
  • In the last 5 years, Neurocrine Biosciences' Assets Average plummeted by 2993.92% in 2017 and then soared by 14813.98% in 2018.
  • Over the past 5 years, Neurocrine Biosciences' Assets Average (Quarter) stood at $795.0 million in 2017, then increased by 21.18% to $963.4 million in 2018, then grew by 29.01% to $1.2 billion in 2019, then soared by 30.22% to $1.6 billion in 2020, then grew by 22.75% to $2.0 billion in 2021.
  • Its last three reported values are $2.0 billion in Q3 2021, $1.9 billion for Q2 2021, and $1.8 billion during Q1 2021.